[Value of lymphoblastic transformation test (L.T.T.) in the diagnosis of delayed hypersensitivity and drug intolerance (682 cases)].
D000937:Antigen-Antibody Reactions; D001241:Aspirin; D001426:Bacterial Proteins; D002002:Brucella / Q000276:immunology; D002175:Candida / Q000276:immunology; D004167:Diphtheria Toxin; D004342:Drug Hypersensitivity / Q000175:diagnosis*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000175:diagnosis*; D007455:Iodine; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D013291:Streptococcus / Q000276:immunology; D013744:Tetanus Toxin; D014374:Tuberculin Test; D014436:Typhoid-Paratyphoid Vaccines
D001426:Bacterial Proteins; D004167:Diphtheria Toxin; D013744:Tetanus Toxin; D014436:Typhoid-Paratyphoid Vaccines; D007455:Iodine; D001241:Aspirin
Intérêt du test de transformation lymphoblastique (T.T.L.) dans le diagnostic de l'hypersensibilité retardée et l'intolérance médicamenteuse (682 cas)